Weight loss drug linked to lower risk of eye disease in patients with diabetes, finds study Written By Dr. Kamal Kant Kohli2 March 2026 11:30 AM ISTThe popular diabetes and weight loss medication tirzepatide (brand name Mounjaro or Zepbound) may lower the risk of diabetic retinopathy, a leading...
FDA Approves Oral Desmopressin for Central Diabetes Insipidus Written By Dr. Kamal Kant Kohli1 March 2026 8:30 PM ISTThe U.S. Food and Drug Administration has approved desmopressin acetate oral solution (Desmoda) for the treatment of central diabetes insipidus in...
Nanoparticle System Shows Promise for Delivering mRNA to Prevent Type 1 Diabetes, suggests study Written By Dr. Kamal Kant Kohli1 March 2026 8:30 PM ISTResearch on preventing type 1 diabetes often focuses on limiting the autoimmune response that destroys the body's ability to produce its own insulin....
HbA1c Variability may increase risk of Renal and Retinal Complications in Diabetes, finds study Written By Dr. Shravani Dali28 Feb 2026 10:45 AM ISTResearchers have found in a new research that greater HbA1c variability is associated with an increased risk of adverse renal events and retinal...
Cardiovascular Medicine 2025: Landmark Dyslipidaemia Studies Redefine Lipid Management Written By Medha Baranwal27 Feb 2026 8:30 PM ISTTurkey: The year 2025 marked a turning point in dyslipidaemia research, with major advances reshaping how lipid-related cardiovascular risk is...
GLP-1 drugs combined with healthy lifestyle habits linked with reduced cardiovascular risk among diabetes patients: Study Written By Dr. Kamal Kant Kohli27 Feb 2026 9:30 AM ISTIndividuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist...
Type 2 Diabetes and Diabetic Retinopathy Linked to Higher Dementia Risk: New Study Reveals Written By Medha Baranwal26 Feb 2026 8:15 PM ISTUSA: A large study published in the American Journal of Ophthalmology has revealed that individuals with type 2 diabetes have a higher risk of...
Anagliptin-Metformin Combo Safe in Type 2 Diabetes With Moderate Renal Impairment: AMELIO Study Written By Medha Baranwal26 Feb 2026 9:00 AM ISTJapan: A fixed-dose combination of anagliptin and metformin appears to be safe for patients with type 2 diabetes mellitus (T2DM) who also have...
Dobutamine Stress Echo for Liver Transplant: High Specificity, Low Sensitivity for Pre-Transplant Cardiac Risk, June 2025, IHJ Study Finds Written By Aashi verma26 Feb 2026 8:15 AM ISTA recent cross-sectional study found that dobutamine stress echocardiography (DSE) provides high specificity (97.4%) for ruling out cardiac-related...
Why do people living at high altitudes have better glucose control? The answer was in plain sight Written By Dr. Kamal Kant Kohli25 Feb 2026 8:45 PM ISTIn a 2023 paper on hypoxia and glucose metabolism, our lab showed how organisms rewire their metabolism to adapt to low oxygen levels-such as those...
Hormones Not to Blame? Study Finds Psychosocial Factors Behind Sexual Dysfunction in Opioid Dependence Written By Aashi verma25 Feb 2026 8:30 PM ISTIndia: A recent study published in the Indian Journal of Medical Research in December 2025 reports that sexual dysfunction is nearly universal among...
Maternal Diabetes During Pregnancy Linked to Increased Epilepsy Risk in Offspring: Study Written By Medha Baranwal25 Feb 2026 8:30 PM ISTCanada: Researchers have found in a retrospective population-based study from Canada that children born to mothers with any form of diabetes—including...
